Haleon (HLN) Total Liabilities (2021 - 2026)
Haleon's (HLN) quarterly Total Liabilities came in at -$21.7 billion in Q2 2026, little changed on a QoQ basis from -$21.6 billion in Q4 2025.
Haleon (HLN) Total Liabilities (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Total Liabilities data on file, last reported at -$21.7 billion in Q2 2026.
- Quarterly Total Liabilities changed N/A year-over-year to -$21.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$21.7 billion (changed N/A YoY) and the FY2025 annual result came in at -$21.5 billion, down 192.87% from the prior year.
- Total Liabilities was little changed at -$21.7 billion in Q2 2026, from -$21.6 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $23.2 billion in Q4 2024 to a low of -$22.7 billion in Q2 2022.
- A 5-year average of -$5.3 billion and a median of -$21.3 billion in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 100.4% — and 2025, when it sank 193.16%.
- Tracing HLN's Total Liabilities over 5 years: stood at $21.5 billion in 2022, then declined by 0.13% to $21.5 billion in 2023, then gained by 7.98% to $23.2 billion in 2024, then sank by 193.16% to -$21.6 billion in 2025, then declined by 0.11% to -$21.7 billion in 2026.
- The last three Total Liabilities figures came in at -$21.7 billion (Q2 2026), -$21.6 billion (Q4 2025), and $23.2 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 2.12 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 2.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.66 Bn |
| Dec 31, 2025 | -21.63 Bn |
| Dec 31, 2024 | 23.22 Bn |
| Jun 30, 2024 | -21.07 Bn |
| Dec 31, 2023 | 21.50 Bn |
| Jun 30, 2023 | -22.02 Bn |
| Dec 31, 2022 | 21.53 Bn |
| Jun 30, 2022 | -22.68 Bn |
| Dec 31, 2021 | 10.74 Bn |